Skip to main content
Premium Trial:

Request an Annual Quote

Bioneer Supplying Emory Genetics Lab with PCR Kits

Premium

Bioneer, the US subsidiary of South Korea's Bioneer Corporation, said recently that it has signed a contract to provide PCR kits to Emory Genetics Laboratory, an Emory University-affiliated provider of clinical and laboratory genetic services.

Under the contract, Alameda, Calif.-based Bioneer will supply Emory Genetics Laboratory with AccuPower PyroHotStart PCR kits, which use the company's exclusive PyroHotStart technology. The company expects to supply the laboratory with about 500,000 tests, which may increase by up to 50 percent in the second year.

In addition, Emory Genetics Laboratory will work with Bioneer to provide technical validation and references that may be used as proof sources for other labs, Bioneer said. The contract will be automatically extended on an annual basis, and may change as volumes increase.

According to the company, its AccuPower kits include all necessary reagents and materials lyophilized in individual PCR tubes. Reactions are set up by adding purified nucleic acids, primers, and distilled water to the tubes.

Bioneer said that this procedure reduces setup time and prevents carryover contamination that can occur with standard PCR methods, making the kit suitable for diagnostics and research.

Korea's Bioneer, headquartered in Daejeon, trades publicly on the Kosdaq. Besides its California-based US subsidiary, the company has branches in China and Australia. The company's product portfolio includes real-time PCR diagnostic workstations, automated nucleic acid extraction systems, and diagnostic and sample prep kits.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.